Abstract
GPR50 is an orphan G protein-coupled receptor (GPCR) located on Xq28, a region previously implicated in multiple genetic studies of bipolar affective disorder (BPAD). Allele frequencies of three polymorphisms in GPR50 were compared in case–control studies between subjects with BPAD (264), major depressive disorder (MDD) (226), or schizophrenia (SCZ) (263) and ethnically matched controls (562). Significant associations were found between an insertion/deletion polymorphism in exon 2 and both BPAD (P=0.0070), and MDD (P=0.011) with increased risk associated with the deletion variant (GPR50Δ502–505). When the analysis was restricted to female subjects, the associations with BPAD and MDD increased in significance (P=0.00023 and P=0.0064, respectively). Two other single-nucleotide polymorphisms (SNPs) tested within this gene showed associations between: the female MDD group and an SNP in exon 2 (P=0.0096); and female SCZ and an intronic SNP (P=0.0014). No association was detected in males with either MDD, BPAD or SCZ. These results suggest that GPR50Δ502–505, or a variant in tight linkage disequilibrium with this polymorphism, is a sex-specific risk factor for susceptibility to bipolar disorder, and that other variants in the gene may be sex-specific risk factors in the development of schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kendler KS, Pedersen N, Johnson L, Neale MC, Mathe AA . A pilot Swedish twin study of affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry 1993; 50: 699–700.
Jones I, Kent L, Craddock N . The genetics of affective disorders. In: McGuffin P, Owen MJ, Gottesman II (eds) Psychiatric Genetics and Genomics. Oxford university press: Oxford, England, 2002.
Sullivan PF, Neale MC, Kendler KS . Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552–1562.
Sullivan PF, Kendler KS, Neale MC . Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–1192.
Massat I, Souery D, Del-Favero J, Oruc L, Noethen MM, Blackwood D et al. Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry 2002; 7: 201–207.
Hebebrand J, Hennighausen K . A critical analysis of data presented in eight studies favouring X-linkage of bipolar illness with special emphasis on formal genetic aspects. Hum Genet 1992; 90: 289–293.
Baron M, Freimer NF, Risch N, Lerer B, Alexander JR, Straub RE et al. Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nat Genet 1993; 3: 49–55.
Berrettini W . Progress and pitfalls: bipolar molecular linkage studies. J Affect Disord 1998; 50: 287–297.
Baron M . Genetic linkage and bipolar disorder: a cautionary note. J Affect Disord 2001; 67: 267–273.
Bocchetta A, Piccardi MP, Martinelli V, Quesada G, Del Zompo M . Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in Sardinia. Psychiatr Genet 1999; 9: 63–68.
Pekkarinen P, Terwilliger J, Bredbacka PE, Lonnqvist J, Peltonen L . Evidence of a predisposing locus to bipolar disorder on Xq24–q27.1 in an extended Finnish pedigree. Genome Res 1995; 5: 105–115.
Ekholm JM, Kieseppa T, Hiekkalinna T, Partonen T, Paunio T, Perola M et al. Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 2003; 12: 1907–1915.
Muller DJ, Schulze TG, Jahnes E, Cichon S, Krauss H, Kesper K et al. Association between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorder. Am J Med Genet 2002; 114: 74–78.
Gubitz AK, Reppert SM . Assignment of the melatonin-related receptor to human chromosome X (GPR50) and mouse chromosome X (Gpr50). Genomics 1999; 55: 248–251.
Reppert SM, Weaver DR, Ebisawa T, Mahle CD, Kolakowski Jr LF . Cloning of a melatonin-related receptor from human pituitary. FEBS Lett 1996; 386: 219–224.
Conway S, Drew JE, Mowat ES, Barrett P, Delagrange P, Morgan PJ . Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor. J Biol Chem 2000; 275: 20602–20609.
American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, (4th Edn). APA: Washington, DC.
Endicott J, Spitzer RL . A Diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psych 1978; 35: 837–862.
Ghaemi SN, Ko JY, Goodwin FK . ‘Cade's disease’ and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002; 47: 125–134.
Smith DJ, Harrison N, Muir W, Blackwood DHR . Bipolar spectrum disorders in young adults with recurrent depression: comparison of structured diagnostic criteria with a manic symptoms checklist. J Affect Disord 2004 (in press).
Zhao JH, Curtis D, Sham PC . Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133–139.
Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–221.
UCSC Genome Browser.http://genome.ucsc.edu/.
Donald JA, Salmon JA, Adams LJ, Littlejohn T, Maher A, Mitchell PB et al. Parental sex effects in bipolar affective disorder pedigrees. Genet Epidemiol 1997; 14: 611–616.
Ferguson SS . Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53: 1–24, Review.
Chuang TT, Iacovelli L, Sallese M, De Blasi A . G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trend Pharmacol Sci 1996; 17: 416–421.
Brady AE, Limbird LE . G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal 2002; 14: 297–309.
Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M . A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999; 401: 286–290.
Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE et al. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry 2003; 8: 546–557.
Bunemann M, Hosey MM . G-protein coupled receptor kinases as modulators of G-protein signalling. J Physiol 1999; 517 (Part 1): 5–23.
Liu HX, Cartegni L, Zhang MQ, Krainer AR . A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 2001; 27: 55–58.
Rubinsztein DC, Leggo J, Goodburn S, Walsh C, Jain S, Paykel ES . Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet 1996; 5: 779–782.
Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC . Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000; 96: 36–42.
Saito T, Parsia S, Papolos DF, Lachman HM . Analysis of the pseudoautosomal X-linked gene SYBL1in bipolar affective disorder: description of a new candidate allele for psychiatric disorders. Am J Med Genet 2000; 96: 317–323.
Hawi Z, Mynett-Johnson L, Gill M, Murphy V, Straubl RE, Kendler KS et al. Pseudoautosomal gene: possible association with bipolar males but not with schizophrenia. Psychiatr Genet 1999; 9: 129–134, Erratum in: Psychiatr Genet 1999; 9: 209.
Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV et al. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000; 96: 801–803.
Stine OC, McMahon FJ, Chen L, Xu J, Meyers DA, MacKinnon DF et al. Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet 1997; 74: 263–269.
Carrel L, Cottle AA, Goglin KC, Willard HF . A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci USA 1999; 96: 14440–14444.
Geerkens C, Vetter U, Just W, Fedarko NS, Fisher LW, Young MF et al. The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X–Y homologous gene. Hum Genet 1995; 96: 44–52.
Xu J, Burgoyne PS, Arnold AP . Sex differences in sex chromosome gene expression in mouse brain. Hum Mol Genet 2002; 11: 1409–1419.
Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-Leeper G et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997; 387: 705–708.
Stokes PE . The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 1995; 5: 77–82.
Rybakowski JK, Twardowska K . The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 1999; 33: 363–370.
Pariante CM . Depression, stress and the adrenal axis. J Neuroendocrinol 2003; 15: 811–812.
Toren P, Dor J, Rehavi M, Weizman A . Hypothalamic-pituitary-ovarian axis and mood. Biol Psychiatry 1996; 40: 1051–1055.
Halbreich U, Lumley LA . The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 1993; 29: 159–173.
Zubenko GS, Hughes III HB, Maher BS, Stiffler JS, Zubenko WN, Marazita ML . Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 2002; 114: 980–987.
Zubenko GS, Hughes III HB, Stiffler JS, Brechbiel A, Zubenko WN, Maher BS et al. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry 2003; 8: 611–618.
Lazennec G, Thomas JA, Katzenellenbogen BS . Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators. J Steroid Biochem Mol Biol 2001; 77: 193–203.
Acknowledgements
We thank Peter Visscher for statistical advice and discussion, and Kirsty Millar for critical reading of this manuscript. This work was supported by Organon Laboratories Ltd, Newhouse, Lanarkshire, UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomson, P., Wray, N., Thomson, A. et al. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol Psychiatry 10, 470–478 (2005). https://doi.org/10.1038/sj.mp.4001593
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001593
Keywords
This article is cited by
-
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Signal Transduction and Targeted Therapy (2023)
-
Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications
Molecular Biology Reports (2023)
-
GPR50-Ctail cleavage and nuclear translocation: a new signal transduction mode for G protein-coupled receptors
Cellular and Molecular Life Sciences (2020)
-
Melatonin: an endogenous miraculous indolamine, fights against cancer progression
Journal of Cancer Research and Clinical Oncology (2020)
-
Melatonin and its ubiquitous anticancer effects
Molecular and Cellular Biochemistry (2019)